Summary
Edwards Lifesciences (EW) filed an 8-K on October 27, 2022, to announce its financial results for the third quarter of 2022. The filing primarily consists of a press release that details the company's performance during the period. Investors should pay close attention to the revenue, earnings per share, and any forward-looking guidance provided in the press release for a comprehensive understanding of the company's current financial health and future outlook.
Key Highlights
- 1The 8-K filing includes a press release detailing Edwards Lifesciences' financial results for the third quarter of 2022.
- 2The press release, furnished as Exhibit 99.1, provides the company's reported financial performance for the Q3 2022 period.
- 3This filing serves as the official notification of the company's Q3 2022 financial outcomes.
- 4Investors can find specific details on revenue, profitability, and other key financial metrics within the referenced press release.
- 5The information furnished is not deemed 'filed' for purposes of the Securities Exchange Act of 1934, a standard disclosure for press release attachments.
- 6The event date and filing date are both October 26, 2022, indicating the results were released shortly after the reporting period concluded.
Frequently Asked Questions
The main purpose of this 8-K filing is to formally announce Edwards Lifesciences' financial results for the third quarter of 2022. It includes a press release that provides the details of their performance during that period.
The specific financial results for the third quarter of 2022 are contained within the press release, which is furnished as Exhibit 99.1 to this 8-K filing and incorporated by reference.
The 8-K itself does not contain new guidance, but the accompanying press release (Exhibit 99.1) would typically include information on the company's financial performance and potentially forward-looking statements or guidance from management. Investors should review Exhibit 99.1 for this information.
No, the information furnished under Item 2.02, including the press release, is typically furnished and not deemed 'filed' for the purposes of the Securities Exchange Act of 1934. This is a common distinction made for press release materials.